Stein H M, Martinez A, Oyama K, Blount L, Padbury J F
Department of Pediatrics, Georgetown University Medical Center, Washington, District of Columbia 20007.
Am J Physiol. 1995 Jan;268(1 Pt 1):E28-32. doi: 10.1152/ajpendo.1995.268.1.E28.
We previously demonstrated that prenatal corticosteroids attenuated the expected exponential increase in circulating catecholamines at birth. The present studies were undertaken to determine if alteration in sulfoconjugation could account for this attenuation. Catheterized fetal lambs received saline (n = 6) or corticosteroids (n = 8) intravenously for 60 h. The lambs were delivered by cesarean section at 130 +/- 1 days gestation. Ventilatory and cardiovascular responses and plasma catecholamine concentrations were measured for 2 h after birth. Although plasma free catecholamines levels were higher in controls than in corticosteroid-treated fetuses, the sulfoconjugated levels were similar in the two groups. Thus the corticosteroid-treated fetuses had a higher proportion of plasma sulfoconjugated catecholamines consistent with the possibility that sulfoconjugation was augmented during intrauterine life. After birth, the corticosteroid-treated animals showed an attenuated increase in plasma free catecholamine levels compared with controls but a similar increase in sulfoconjugated catecholamine levels to the control animals. The proportion of plasma sulfoconjugated catecholamines was higher in the corticosteroid-treated animals; however, the increase in sulfoconjugated catecholamines was insufficient to account for the attenuated overall increase in total catecholamines in the corticosteroid-treated animals.
我们之前证明,产前使用皮质类固醇可减弱出生时循环儿茶酚胺预期的指数性增加。本研究旨在确定硫酸结合作用的改变是否能解释这种减弱现象。将导管插入的胎羊静脉注射生理盐水(n = 6)或皮质类固醇(n = 8),持续60小时。这些胎羊在妊娠130±1天时通过剖宫产分娩。出生后2小时测量通气和心血管反应以及血浆儿茶酚胺浓度。虽然对照组的血浆游离儿茶酚胺水平高于接受皮质类固醇治疗的胎儿,但两组的硫酸结合物水平相似。因此,接受皮质类固醇治疗的胎儿血浆硫酸结合儿茶酚胺的比例较高,这与宫内生活期间硫酸结合作用增强的可能性相符。出生后,与对照组相比,接受皮质类固醇治疗的动物血浆游离儿茶酚胺水平的增加有所减弱,但硫酸结合儿茶酚胺水平的增加与对照动物相似。接受皮质类固醇治疗的动物血浆硫酸结合儿茶酚胺的比例更高;然而,硫酸结合儿茶酚胺的增加不足以解释接受皮质类固醇治疗的动物总儿茶酚胺总体增加的减弱现象。